ChristinaWiedlDO

Pediatric Hematology & Oncology • Washington, DC

Assistant Professor, Pediatrics, Children's National Hospital; George Washington University School of Medicine and Health Sciences

Join to view full profile

Dr. Wiedl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wiedl's full profile

Already have an account?

Office
111 Michigan Ave NW
Washington, DC 20010
Phone+1 202-476-2800

Fax+1 202-476-5685

Education & Training

University of RochesterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonResidency, Pediatrics, 2004 - 2007
Philadelphia College of Osteopathic MedicineClass of 2004

Certifications & Licensure

VA State License 2011 - 2026
DC State License 2021 - 2024
NY State License 2009 - 2012
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease Start of enrollment: 2012 Mar 01
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Completed
Phase 2
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) Start of enrollment: 2022 Apr 19
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

13 citations
Metabolic effects of acute thiamine depletion are reversed by rapamycin in breast and leukemia cells.
Shuqian Liu, Sumitra Miriyala, Mignon A. Keaton, Craig T. Jordan, Christina M. Wiedl
Plos One. 2014-01-15
25 citations
Role of small intestine submucosa (SIS) as a nerve conduit: preliminary report.
Ryan M. Smith, Christina Wiedl, Paul Chubb, Charlotte H. Greene
Journal of Investigative Surgery. 2004-11-01
18 citations
Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy.
John Preston Claiborne, Dipankar Bandyopathyay, Catherine H. Roberts, Kelly G. Hawks, May Aziz
Leukemia & Lymphoma. 2019-05-03